Delirium Tremens Tugas
Delirium Tremens Tugas
Delirium Tremens Tugas
Delirium Tremens
Preceptor:
dr. Iwan Sys, SpKJ
By:
Dwi Prasetyana Rosadi (201510401011001)
Fajaruddin Ma’ruf (201510401011051)
PSYCHIATRY
MEDICAL FACULTY
UNIVERSITY OF MUHAMMADIYAH MALANG
2017
DEFINITION
Delirium tremens is rare and is a diagnosis by exclusion, so
before commencing treatment, screen for other factors
contributing to delirium, in particular:
subdural haematoma
head injury
Wernicke’s encephalopathy
hepatic encephalopathy
Hypoxia
Sepsis
metabolic disturbances
(Moses, 2012)
Clinical Manifestations
Symptoms most often occur within 48 to 72 hours after the last drink
Seizures
Grand mal seizures
60% of patients; have between 1-6 seizures
Toxicology screening
May indicate other drugs in the system
Electrolyte Panel
Metabolic Acidosis
CT of head
Likely negative
(Epocrates, 2011.)
TREATMENT
Preventive measures.
Medical Care
Prescribe medications for symptoms
Benzodiazepines: Ativan, Diazepam
Anticonvulsants: Tegretol
Thiamine: Vitamin B1
Magnesium sulfate
5% dextrose in 0.45%-0.9% NaCl
(Burns, 2011)
(Kneisl & Trigoboff, 2013)
Clomethiazole
The GABA-ergic model of alcohol withdrawal and
withdrawal delirium favors benzodiazepines in the
treatment.
For adequate alleviation of delirious symptoms, four
to six 300 mg clomethiazole capsules.
Benzodiazepines
short-acting agents are preferred (e.g. lorazepam,
midazolam and oxazepam).
Benzodiazepines (especially clonazepam and diazepam)
are also beneficial in epileptic seizure management as
epileptic activity is a frequent complication seen in
alcohol withdrawal and withdrawal delirium (up to 30%).
They are also the drugs of choice in sedative and
hypnotic withdrawal deliria. Common use in anxiolytic
or other indications (60-90 mg of diazepam equivalent a
day).
Antipsychotics
Tiapride, an atypical D2/D3 antipsychotic agent, can
be used in uncomplicated alcohol withdrawal
syndrome.
the doses can 300 to 1800 mg/day - oral and
parenteral.
Anticonvulsant
The anticonvulsants of non-benzodiazepine type
carbamazepine and oxcarbazepine with likely GABA-
ergic and NMDA-blocking activity represent other
drugs of possible use.
Used in doses of 800 mg a day in both fixed and
tapered regimens.
clinician-rated withdrawal phenomena using fixed or
tapered (over 5-9 days) regimen with 800 mg daily as
an initial dose.
Complications of
Treatment
Oversedation
Respiratory depression **
Aspiration pneumonitis
Cardiac arrhythmias **
(NIH, 2011)
References
Burns, M. (2011). Medscape reference. Retrieved from
http://emedicine.medscape.com/article/166032-overview